Fuller & Thaler Asset Management Inc. Acquires 124,216 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fuller & Thaler Asset Management Inc. boosted its stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 8.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,579,708 shares of the company's stock after buying an additional 124,216 shares during the quarter. Fuller & Thaler Asset Management Inc. owned approximately 0.85% of Doximity worth $84,341,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Shaker Investments LLC OH acquired a new position in Doximity in the fourth quarter worth $559,000. Principal Financial Group Inc. raised its position in shares of Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock worth $15,695,000 after acquiring an additional 4,282 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in Doximity in the fourth quarter valued at about $362,000. Stratos Wealth Partners LTD. bought a new stake in Doximity in the fourth quarter valued at about $203,000. Finally, Wells Fargo & Company MN increased its holdings in Doximity by 3.3% in the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock valued at $19,698,000 after purchasing an additional 11,811 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Price Performance

Shares of DOCS traded up $0.68 during mid-day trading on Tuesday, hitting $57.37. The stock had a trading volume of 400,704 shares, compared to its average volume of 1,984,128. The firm has a market cap of $10.71 billion, a P/E ratio of 57.43, a PEG ratio of 4.10 and a beta of 1.41. The business has a fifty day moving average price of $60.30 and a 200-day moving average price of $56.37. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 37.40% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on DOCS shares. Bank of America upped their price objective on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Truist Financial dropped their price objective on Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a report on Thursday, April 10th. The Goldman Sachs Group boosted their target price on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Canaccord Genuity Group raised their target price on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a report on Friday, February 7th. Finally, Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Doximity has a consensus rating of "Moderate Buy" and a consensus price target of $65.39.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.